CPC A61K 36/71 (2013.01) [A61K 35/60 (2013.01); A61K 47/10 (2013.01); A61P 25/36 (2018.01); A61K 2236/333 (2013.01)] | 12 Claims |
1. A formulation formulated to treat drug addiction withdrawal symptoms, comprising a therapeutically effective amount of:
phospholipid wax extracted from fish roe; and
Nigella sativa seed oil extract,
wherein the phospholipid wax and the Nigella sativa seed oil extract are present in the formulation at a ratio of 1.5:8.5, w/w, and
wherein the formulation is a solid dosage form selected from the group consisting of a tablet, a capsule, a caplet and a gelcap.
|